Phase I Study of C-TPF in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Robert I. Haddad(Georgetown University), Marshall R. Posner(Icahn School of Medicine at Mount Sinai), Tracy A. Balboni(Brigham and Women's Hospital), Lori J. Wirth(Massachusetts General Hospital), Laura A. Goguen(Brigham and Women's Hospital), Donald J. Annino(Harvard University), Charles M. Norris, Roy B. Tishler(Dana-Farber Cancer Institute), Jochen H. Lorch(Northwestern University), Rosemary Costello(Dana-Farber Cancer Institute), Britta Andreozzi(Dana-Farber Brigham Cancer Center)
Cited by 57
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Recent Advances in Head and Neck Cancer
|New England Journal of Medicine|2008|926